Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wollenberg

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Clinical Pharmacology : Advances and Applications|October 23, 2015
An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)Lance A Wollenberg, Donald T Corson, Courtney A Nugent, et al.
Allergy|June 13, 2017
What's in a name? Atopic dermatitis or atopic eczema, but not eczema aloneJ I Silverberg, J P Thyssen, A S Paller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2020
2020 European guideline on the management of genital molluscum contagiosumS Edwards, M J Boffa, M Janier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinionK Potthoff, R Hofheinz, J C Hassel, et al.
The Journal of Dermatological Treatment|April 30, 2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trialsS Barbarot, A Wollenberg, J I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2009
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitisU Darsow, A Wollenberg, D Simon, et al.
The Journal of Investigative Dermatology|November 1, 1992
Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance between shedding and secretion?C de la Salle, M E Esposito-Farese, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2021
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B studyJ I Silverberg, A Pinter, A Alavi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2021
Position statement on the role of nurses in therapeutic patient education in atopic dermatitisK Thormann, H Aubert, S Barbarot, et al.
American Journal of Human Genetics|October 9, 2001
Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndromeC Lefèvre, F Jobard, F Caux, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Clinical Pharmacology : Advances and Applications|October 23, 2015
An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)Lance A Wollenberg, Donald T Corson, Courtney A Nugent, et al.
Allergy|June 13, 2017
What's in a name? Atopic dermatitis or atopic eczema, but not eczema aloneJ I Silverberg, J P Thyssen, A S Paller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2020
2020 European guideline on the management of genital molluscum contagiosumS Edwards, M J Boffa, M Janier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinionK Potthoff, R Hofheinz, J C Hassel, et al.
The Journal of Dermatological Treatment|April 30, 2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trialsS Barbarot, A Wollenberg, J I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2009
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitisU Darsow, A Wollenberg, D Simon, et al.
The Journal of Investigative Dermatology|November 1, 1992
Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance between shedding and secretion?C de la Salle, M E Esposito-Farese, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2021
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B studyJ I Silverberg, A Pinter, A Alavi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2021
Position statement on the role of nurses in therapeutic patient education in atopic dermatitisK Thormann, H Aubert, S Barbarot, et al.
American Journal of Human Genetics|October 9, 2001
Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndromeC Lefèvre, F Jobard, F Caux, et al.
Pageof 18